Related Experiment Video
Updated: May 24, 2026
08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Chromosomal imbalances in primary hepatic carcinosarcoma
Inga-Marie Schaefer1, Stefan Schweyer, Jens Kuhlgatz
1Department of Pathology, University Medical Center Göttingen, Robert-Koch-Straβe 40, D-37075 Göttingen, Germany. schaeferinga@web.de
Human Pathology
|March 13, 2012
Summary
This study investigates hepatic carcinosarcoma, a rare cancer with poor prognosis. Findings suggest a possible monoclonal origin and highlight genetic alterations like +6p, potentially driving tumor progression.
Area of Science:
- Oncology
- Genetics
Background:
- Hepatic carcinosarcoma is a rare biphasic tumor with an unknown origin and poor prognosis.
- Understanding its molecular genetic mechanisms is crucial for improved diagnostics and therapeutics.
Observation:
- A case of hepatic carcinosarcoma in a 76-year-old patient was surgically resected and analyzed.
- Histopathology and immunohistochemistry revealed focal hepatocellular differentiation in both carcinomatous and spindle cell components.
Findings:
- Comparative genomic hybridization identified distinct genetic alterations in carcinomatous and sarcomatous components.
- A common amplification (+6p) was observed in both components, encompassing the serum response factor gene, implicated in cell proliferation and migration.
Implications:
- Hepatic carcinosarcoma may arise from a monoclonal origin, despite its biphasic morphology.
- The identified genetic aberrations, particularly +6p, offer insights into tumor progression and potential therapeutic targets.
